Wealthspire Advisors (Maryland)’s Juno Therapeutics, Inc. JUNO Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-94	Closed	-$4K	–	2739
2017 Q4	$4K	Sell	94 -3,478	-97%	-$173K	﹤0.01%	1954
2017 Q3	$160K	Buy	3,572 +3,559	+27,377%	+$121K	0.02%	555
2017 Q2	$0	Hold	13	–	–	﹤0.01%	2348
2017 Q1	$0	Buy	+13	New	+$279	﹤0.01%	2087

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Wealthspire Advisors (Maryland)'s JUNO Position: Q1 2018 in Review

Wealthspire Advisors (Maryland) sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 94 shares — an estimated $4K sold.

Wealthspire Advisors (Maryland) first reported a position in JUNO in Q1 2017 and held it in 4 quarters. The position peaked at $160K in Q3 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Wealthspire Advisors (Maryland) reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Wealthspire Advisors (Maryland) sold 94 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $4K.
Wealthspire Advisors (Maryland) first reported a position in Juno Therapeutics, Inc. in Q1 2017 and held it in 4 quarters.
Wealthspire Advisors (Maryland)'s Juno Therapeutics, Inc. position peaked at $160K in Q3 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2018, filed 3 May 2018.